Delivery Order SPE2DR25D2009-SPE2DR26FJ3W6
- Not listed
- The Defense Logistics Agency (DLA) awarded a $10,186.15 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The sensors will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a $5,575.44 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus continuous glucose monitoring sensors, with an ultimate completion date of October 16, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be...
- The Defense Logistics Agency awarded a delivery order valued at $4,368.94 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on October 17, 2025, with completion expected by October 20, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The sensors will be supplied from the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors valued at $6,119.27 on December 3, 2025, with an ultimate completion date of December 4, 2025. This firm fixed price delivery order represents a non-competitive set-aside contract and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a $1,950.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for Freestyle Libre 3 Plus Sensors, with completion expected by December 8, 2025. This non-set-aside award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,133.58 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on December 8, 2025, with an ultimate completion date of December 9, 2025. This is a firm fixed price, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania facility. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion...
- The Defense Logistics Agency (DLA) awarded a $10,845.73 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with an ultimate completion date of September 30, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,665.21 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on October 30, 2025, with an ultimate completion date of October 31, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,144.64 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with an ultimate completion date of September 26, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX). The sensors will be performed at AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,706.68 to AmerisourceBergen Drug Corp for Freestyle Libre 3 sensors, with a completion date of November 17, 2025. This is a firm fixed-price, non-set-aside contract issued on November 14, 2025, with performance taking place at the contractor's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- SPE2DR25D2009Indefinite Delivery Contract
- SPE2DR25D2009-SPE2DR26FJ3W6Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,535.89 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with a completion date of December 8, 2025. This is a firm fixed price, non-set-aside contract issued as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award represents a continuation of the company's role as a critical pharmaceutical and medical device supplier to the federal government, specifically supporting military and veteran healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, holds a $999,999,999 prime IDC (SPE2DX) with DLA Troop Support Medical through December 2026, which serves as the vehicle for this delivery order. The company is a major pharmaceutical distributor providing a comprehensive range of medical products including specialty medications, vaccines, medical devices, and healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. This award of continuous glucose monitoring sensors demonstrates the company's ongoing fulfillment of specialized medical supply needs within the DLA's global pharmaceutical support framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 12/4/25 |